31/05/2013
Solidarity contracts for 730 scientific representatives of the 4 companies of the Menarini pharmaceutical group in Florence. This is what was proposed by General Manager Domenico Simone in a meeting with Undersecretary Claudio De Vincenti at the Ministry of Economic Development today in Rome. Last October the Group, owned by the Aleotti family, had announced a total of 1,000 redundancies after the entry into force of the Balduzzi decree which requires doctors to write the name of the active ingredient in the prescription.
"We have proposed using solidarity contracts, and not other more dramatic solutions, because we are well aware of the social and employment problems of the moment" said the director general of the Menarini Group, Domenico Simone, leaving the ministry.
"Unfortunately, the general situation for us has not improved so much that while the manufacturers of generic drugs a few days ago used triumphal tones to report a growth in 25%, we continue to have problems".
Between 2010 and the end of 2012, the pharmaceutical group had reported a drop in turnover of around 35%. "Undersecretary Claudio De Vincenti – continued Simone – appreciated our proposal, as did the trade unions present. Now we will have to have a meeting at the Ministry of Labour, but let's hope there are no problems".
In total, there are 1600/1700 scientific representatives of the Group: the solidarity contracts would therefore affect approximately 45%. As for the other 270 workers at risk, there were 1,000 redundancies announced in October and then 'suspended' by the company after the interventions of local and national institutions, Simone explains that "this is a situation that remains suspended: the undersecretary assured us that there will be interventions in the sector".
"The situation of the pharmaceutical sector in Italy is extremely critical, with a serious market difficulty especially
